Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026) Profit Margin

Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026) posts a profit margin of -4373.01% as of June 2025. That is below the Healthcare sector average of 13.89%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Healthcare stocks, a profit margin near 13.89% is typical. Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026)'s -4373.01% is lower that level. That is roughly 31576.2% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -4373.01% as of June 2025; use YoY and peer views to separate noise from signal.

Context for IINNW's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.89%), and (3) consistency with growth and profitability. This page covers the first two; Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026)'s other metric pages and overview cover the third.

Judging Inspira Technologies Oxy B.H.N. Ltd - Warrants (30/06/2026) against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in profit margin easier to interpret. Start with -4373.01% here, then scan peer and history charts to see if the gap is persistent.